16.01.2014 • Topics

Helsinn Reaps Benefits of Cytotoxic Molecule Demand

Continue with login

No account yet?

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Company

Helsinn Chemicals SA

Via Industria 24
6710 Biasca
Switzerland

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

most read

Topics • Pharma

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma

Part 1: Building a Business Case for Pharma 4.0

20 Years of CHEManager International

Incredible but true: CHEManager International is celebrating its 20th anniversary!

Topics • Chemistry

Relocation of Chemicals Production Footprint in Full Swing

A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.

Topics • Chemistry

US Tariffs Fatal for European Pharma

Trump's tariff policy is a considerable burden and a break with previous practice.

Topics • Pharma

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma

Part 3: Seven Theses for successful Digitalization in Pharma